ONS-ONCC CHEMOTHERAPY-IMMUNOTHERAPY LESSON
11 TARGETED THERAPIES EXAM QUESTIONS WITH
CORRECT ANSWERS
HowFtargetedFtherapyFandFchemoFdifferF-FCORRECTFANSWERS-
targetedFtherapiesFactFonFspecificFmolecularFtargetsFonForFwithinFtheFcellsFthatFareFassociatedFwith
Fcancer,FwhereasFstandardFchemoFactFonFallFrapidlyFdividingFcells-chemoFhasFmoreFSEs-
targetedFtherapyFaeFchosenFandFdesignedFtoFinteractFwithFtheirFtargetFonForFwithinFtheFcells,Fwher
easFchemoFwereFIDedFbecausedFtheyFkillFcells-
targetedFtherapiesFareFoftenFcytostaticF(theyFblockFtumorFcellFproliferation)FwhereasFchemoFagent
sFareFcytotoxicF(killFtumorFcells)
GoalsFofFtargetedFtherapyF-FCORRECTFANSWERS-
diseaseFcureFwhenFusedFasFprimaryForFadjuvantFtherapy
-improvingFoverallFresponseForFincreaseFdisease-
freeFsurvivalFwhenFusedFinFcombinationFwithFconventionalFtherapies
-controllingForFstabilizingFdisease
-maintainingForFenhancingFqualityFofFlife
-decreasingFtheFseverityFofFtoxicitiesFfromFotherFtherapies
LigandF-
FCORRECTFANSWERSaFsubstanceFthatFformsFaFcomplexFwithFanotherFbiomoleculeFtoFexertFaFbiolog
icFeffect
LigandFBindingF-
FCORRECTFANSWERSprocessFbyFwhichFtheFligandFattachesFtoFaFspecificFreceptorFsiteFandFactivatesF
thatFreceptor,FactivatingFtheFsignalingFpathway
DimerizationF-FCORRECTFANSWERStwoFmonomersFthatFareFside-by-
sideFonFtheFsurfaceFofFtheFcellFareFpairedFandFactivatedFbyFaFligand,FwhichFcausesFaFseriesFofFsignal
s
, KinaseF-
FCORRECTFANSWERStypeFofFenzymeFthatFaddsFchemicalsFcalledFphosphatesFtoFotherFmoleculesFsu
chFasFsugarsForFproteinsFcausingFotherFmoleculesFinFtheFcellFtoFbecomeFeitherFactiveForFinactive
phosphorylationF-FCORRECTFANSWERSactivationFofFaFchemicalFprocessFtoFinitiateFsignaling
targetedFtherapiesFworkFbyFdoingFtheFfollowingF-FCORRECTFANSWERS1.FblockingFangiogenesis
2.FblockingFsignalsFinsideForFoutsideFtheFcell
3.FdeliveringFtoxicFsubstancesFtoFtheFcell
4.FstimulatingFtheFbody'sFimmuneFsystem
BCR/ABLF-FCORRECTFANSWERS-
fusionFproteinFtyrosineFkinaseFformedFwithFaFgeneFtranslocationFoccursFbetweenFgeneF9FandF22-
geneFabnormalityFcalledFtheFPhiladelphiaFchromosomeFseenFinFCMLFandFALL
VEGFF-FCORRECTFANSWERSthisFisFtheFprimaryFangiogenicFfactorFproducedFbyFcells
mTORF-FCORRECTFANSWERS-targetFofFrapamycin-
aFproteinFthatFtellsFcellsFwhenFtoFgrow,Fdivide,FandFsurvive
TwoFwaysFthatFangiogenesisFinhibitorsFworkF-
FCORRECTFANSWERS1.FsomeFintergereFwithFactionFofFVEGFFwhichFstimulatesFnFewFbloodFvesselFfor
mation2.FothersFtargetFtheirFmoleculesFthatFstimulateFnewFbloodFvesselFgrowth
SmallFMoleculeFCompoundFTargetedFTherapiesF-FCORRECTFANSWERS-endFinF-ib-
targetsFlocatedFinsideFtheFcellFbecauseFtheseFgentsFareFableFtoFenterFcellsFmoreFeasily-
intracellular-mostFgivenForally
11 TARGETED THERAPIES EXAM QUESTIONS WITH
CORRECT ANSWERS
HowFtargetedFtherapyFandFchemoFdifferF-FCORRECTFANSWERS-
targetedFtherapiesFactFonFspecificFmolecularFtargetsFonForFwithinFtheFcellsFthatFareFassociatedFwith
Fcancer,FwhereasFstandardFchemoFactFonFallFrapidlyFdividingFcells-chemoFhasFmoreFSEs-
targetedFtherapyFaeFchosenFandFdesignedFtoFinteractFwithFtheirFtargetFonForFwithinFtheFcells,Fwher
easFchemoFwereFIDedFbecausedFtheyFkillFcells-
targetedFtherapiesFareFoftenFcytostaticF(theyFblockFtumorFcellFproliferation)FwhereasFchemoFagent
sFareFcytotoxicF(killFtumorFcells)
GoalsFofFtargetedFtherapyF-FCORRECTFANSWERS-
diseaseFcureFwhenFusedFasFprimaryForFadjuvantFtherapy
-improvingFoverallFresponseForFincreaseFdisease-
freeFsurvivalFwhenFusedFinFcombinationFwithFconventionalFtherapies
-controllingForFstabilizingFdisease
-maintainingForFenhancingFqualityFofFlife
-decreasingFtheFseverityFofFtoxicitiesFfromFotherFtherapies
LigandF-
FCORRECTFANSWERSaFsubstanceFthatFformsFaFcomplexFwithFanotherFbiomoleculeFtoFexertFaFbiolog
icFeffect
LigandFBindingF-
FCORRECTFANSWERSprocessFbyFwhichFtheFligandFattachesFtoFaFspecificFreceptorFsiteFandFactivatesF
thatFreceptor,FactivatingFtheFsignalingFpathway
DimerizationF-FCORRECTFANSWERStwoFmonomersFthatFareFside-by-
sideFonFtheFsurfaceFofFtheFcellFareFpairedFandFactivatedFbyFaFligand,FwhichFcausesFaFseriesFofFsignal
s
, KinaseF-
FCORRECTFANSWERStypeFofFenzymeFthatFaddsFchemicalsFcalledFphosphatesFtoFotherFmoleculesFsu
chFasFsugarsForFproteinsFcausingFotherFmoleculesFinFtheFcellFtoFbecomeFeitherFactiveForFinactive
phosphorylationF-FCORRECTFANSWERSactivationFofFaFchemicalFprocessFtoFinitiateFsignaling
targetedFtherapiesFworkFbyFdoingFtheFfollowingF-FCORRECTFANSWERS1.FblockingFangiogenesis
2.FblockingFsignalsFinsideForFoutsideFtheFcell
3.FdeliveringFtoxicFsubstancesFtoFtheFcell
4.FstimulatingFtheFbody'sFimmuneFsystem
BCR/ABLF-FCORRECTFANSWERS-
fusionFproteinFtyrosineFkinaseFformedFwithFaFgeneFtranslocationFoccursFbetweenFgeneF9FandF22-
geneFabnormalityFcalledFtheFPhiladelphiaFchromosomeFseenFinFCMLFandFALL
VEGFF-FCORRECTFANSWERSthisFisFtheFprimaryFangiogenicFfactorFproducedFbyFcells
mTORF-FCORRECTFANSWERS-targetFofFrapamycin-
aFproteinFthatFtellsFcellsFwhenFtoFgrow,Fdivide,FandFsurvive
TwoFwaysFthatFangiogenesisFinhibitorsFworkF-
FCORRECTFANSWERS1.FsomeFintergereFwithFactionFofFVEGFFwhichFstimulatesFnFewFbloodFvesselFfor
mation2.FothersFtargetFtheirFmoleculesFthatFstimulateFnewFbloodFvesselFgrowth
SmallFMoleculeFCompoundFTargetedFTherapiesF-FCORRECTFANSWERS-endFinF-ib-
targetsFlocatedFinsideFtheFcellFbecauseFtheseFgentsFareFableFtoFenterFcellsFmoreFeasily-
intracellular-mostFgivenForally